American Vanguard Corporation (FRA:AVJ)

Market Cap	55.96M -57.6%
Revenue (ttm)	446.69M -3.5%
Net Income	-47.78M
EPS	-1.67
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.820
Previous Close	1.860
Day's Range	1.820 - 1.820
52-Week Range	1.715 - 5.270
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About American Vanguard

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liq...

• Industry: Agricultural Chemicals
• Founded: 1969
• Employees: 739
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AVJ

Financial Performance

In 2025, American Vanguard's revenue was $515.11 million, a decrease of -5.88% compared to the previous year's $547.31 million. Losses were -$49.88 million, -60.52% less than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error